3218 Stock Overview
Operates a chain of eye care clinics in Taiwan and China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 3218 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Universal Vision Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$202.00 |
| 52 Week High | NT$307.00 |
| 52 Week Low | NT$200.00 |
| Beta | 0.78 |
| 1 Month Change | -6.26% |
| 3 Month Change | -19.84% |
| 1 Year Change | -26.68% |
| 3 Year Change | -19.99% |
| 5 Year Change | 233.08% |
| Change since IPO | 1,027.57% |
Recent News & Updates
Recent updates
Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 03
The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?
Mar 26Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 08The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention
Feb 07Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 17
Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly
Dec 27Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)
Dec 06Shareholder Returns
| 3218 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | 0.4% |
| 1Y | -26.7% | -10.8% | 28.7% |
Return vs Industry: 3218 underperformed the TW Healthcare industry which returned -10.8% over the past year.
Return vs Market: 3218 underperformed the TW Market which returned 28.7% over the past year.
Price Volatility
| 3218 volatility | |
|---|---|
| 3218 Average Weekly Movement | 3.5% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 3218 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 3218's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Pi-Jung Lin | www.uvb.com.tw/ |
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices.
Universal Vision Biotechnology Co., Ltd. Fundamentals Summary
| 3218 fundamental statistics | |
|---|---|
| Market cap | NT$17.11b |
| Earnings (TTM) | NT$1.08b |
| Revenue (TTM) | NT$4.18b |
15.9x
P/E Ratio4.1x
P/S RatioIs 3218 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3218 income statement (TTM) | |
|---|---|
| Revenue | NT$4.18b |
| Cost of Revenue | NT$1.68b |
| Gross Profit | NT$2.50b |
| Other Expenses | NT$1.42b |
| Earnings | NT$1.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.73 |
| Gross Margin | 59.77% |
| Net Profit Margin | 25.78% |
| Debt/Equity Ratio | 13.5% |
How did 3218 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield55%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 23:16 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Universal Vision Biotechnology Co., Ltd. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Regina Lee | Capital Securities Corporation |
| Hui-Chao Hsu | Citigroup Inc |
| Corinne Jian | Macquarie Research |